Skip to content
The GLP-1 Verdict
Menu
Ranked #157 · Grade C

altRX review

altRX is a dual-modality telehealth platform offering compounded GLP-1s plus all four brand-name FDA-approved options — Mounjaro, Ozempic, Wegovy, and Zepbound — the most comprehensive brand-name lineup in…

altRX — FDA warning letter, June 2026. Addressed to Trinity HealthCare Supply, LLC dba altRx, and public in FDA’s warning-letter database.

Visit altRX Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $149/mo (starting dose, compounded)
Tirzepatide
From $249/mo (starting dose, compounded)
Coverage
Not disclosed
Brand-name
Yes

The scorecard

altRX scored on our six published factors. See the methodology.

Real-world results80/100
Price honesty64/100
Prescriber access57/100
Formulary choice90/100
Cancellation fairness56/100
Member support74/100

What we like

  • Offers all four brand-name FDA-approved GLP-1s (Mounjaro, Ozempic, Wegovy, Zepbound) — the most comprehensive brand-name access we've reviewed
  • Publishes the FDA compounded-medication disclaimer
  • Transparent pricing across all six product tiers (compounded plus four brand-name)
  • All-inclusive pricing — consult, prescription, and shipping with no hidden fees

The caveats

  • States-served list not disclosed
  • 503A/503B pharmacy partner not named (only 'multiple USA-certified pharmacies')
  • 503A vs 503B designation not specified
  • No named medical director
  • Corporate physical address not disclosed
  • FDA issued a warning letter to Trinity HealthCare Supply, LLC dba altRx in June 2026; it is public in FDA's warning-letter database

The verdict

Best for: Shoppers who want the only platform offering all four brand-name GLP-1s plus compounded. altRX is a dual-modality telehealth platform offering compounded GLP-1s plus all four brand-name FDA-approved options — Mounjaro, Ozempic, Wegovy, and Zepbound — the most comprehensive brand-name lineup in…

Ranked #157 of 539 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. In the ranking it sits between Oria Meds at #156, 70/100 above and AMP Health at #158, 70/100 below, with the Bionomy Health ruling the next one down.

A grade C is a ranking, not an instruction to stop looking: the closest rivals to altRX are ruled on the identical rubric, so the comparison is like for like.This ruling sits inside a bigger one: the complete ranking puts this ruling in context against every program we track. We have also ruled on it directly: CoreAge Rx vs altRX goes to CoreAge Rx, 94/100 to 70/100.

Compare with other providers

The closest rulings to altRX by Verdict Score — the realistic shortlist if you are weighing this one up.

Browse all 539 rulings, ranked →

Pricing, states and verification reflect altRX's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on altRX's site. Not medical advice; see our disclosure.

← Back to all rankings